PRTC Relative Valuation - PureTech Health PLC - Alpha Spread
P

PureTech Health PLC
NASDAQ:PRTC

Watchlist Manager
PureTech Health PLC
NASDAQ:PRTC
Watchlist
Price: 19.3615 USD -0.28% Market Closed
Market Cap: 463.4m USD
Have any thoughts about
PureTech Health PLC?
Write Note

Relative Value

The Relative Value of one PRTC stock under the Base Case scenario is 9.3658 USD. Compared to the current market price of 19.3615 USD, PureTech Health PLC is Overvalued by 52%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PRTC Relative Value
Base Case
9.3658 USD
Overvaluation 52%
Relative Value
Price
P
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
6
vs Industry
12
Median 3Y
50.6
Median 5Y
45.7
Industry
7.7
Forward
183.5
vs History
vs Industry
Median 3Y
-11.7
Median 5Y
-12.2
Industry
23.9
Forward
-27.7
vs History
vs Industry
Median 3Y
-4.4
Median 5Y
-4.6
Industry
22.2
vs History
vs Industry
Median 3Y
-4.2
Median 5Y
-4.4
Industry
24
vs History
39
vs Industry
58
Median 3Y
1.4
Median 5Y
1.4
Industry
2.5
vs History
vs Industry
16
Median 3Y
26.7
Median 5Y
21.7
Industry
7.4
Forward
-8.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.5
vs History
0
vs Industry
Median 3Y
-2
Median 5Y
-2.3
Industry
5.1
Forward
0.1
vs History
0
vs Industry
Median 3Y
-1.9
Median 5Y
-2.2
Industry
4.7
Forward
0.1
vs History
0
vs Industry
Median 3Y
-2
Median 5Y
-2.6
Industry
6.6
vs History
0
vs Industry
Median 3Y
-2
Median 5Y
-2.6
Industry
4.7
vs History
vs Industry
63
Median 3Y
1
Median 5Y
1.1
Industry
4.7

Multiples Across Competitors

PRTC Competitors Multiples
PureTech Health PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
PureTech Health PLC
NASDAQ:PRTC
463.4m USD 990.1 -5.6 0.2 0.2
US
Abbvie Inc
NYSE:ABBV
341.5B USD 6.2 64.5 15.7 24.1
US
Amgen Inc
NASDAQ:AMGN
180.5B USD 5.8 57.7 20.2 36.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
129B USD 9.6 29.8 26.2 29
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.6B USD 12 -252.2 26.8 28.2
US
Gilead Sciences Inc
NASDAQ:GILD
105B USD 3.8 99.7 9.5 12
US
Epizyme Inc
F:EPE
94.1B EUR 1 975 -504 -548.8 -534.2
AU
CSL Ltd
ASX:CSL
142.3B AUD 6.5 36.4 22.3 27.8
US
Seagen Inc
F:SGT
39.3B EUR 19 -58.3 -62.8 -56.7
US
Palatin Technologies Inc
LSE:0KF3
38.5B USD 6 513.5 -1 169.6 -1 185.3 -1 173.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
35.2B USD 15 -483 212.6 327.3
P/E Multiple
Earnings Growth
US
P
PureTech Health PLC
NASDAQ:PRTC
Average P/E: 57.6
Negative Multiple: -5.6
N/A
US
Abbvie Inc
NYSE:ABBV
64.5
406%
US
Amgen Inc
NASDAQ:AMGN
57.7
74%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
29.8
56%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -252.2
38%
US
Gilead Sciences Inc
NASDAQ:GILD
99.7
71%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -504 N/A
AU
CSL Ltd
ASX:CSL
36.4
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.3 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 169.6 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -483 N/A
EV/EBITDA Multiple
EBITDA Growth
US
P
PureTech Health PLC
NASDAQ:PRTC
Average EV/EBITDA: 41.7
0.2
N/A
US
Abbvie Inc
NYSE:ABBV
15.7
28%
US
Amgen Inc
NASDAQ:AMGN
20.2
57%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
26.2
47%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.8
39%
US
Gilead Sciences Inc
NASDAQ:GILD
9.5
10%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -548.8 N/A
AU
CSL Ltd
ASX:CSL
22.3
45%
US
S
Seagen Inc
F:SGT
Negative Multiple: -62.8 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 185.3 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
212.6
N/A

See Also

Discover More
Back to Top